BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22360506)

  • 1. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS; Kim YS; Kim DK; Park SI; Jang SJ
    Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
    Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global histone modifications predict prognosis of resected non small-cell lung cancer.
    Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
    J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome].
    Passlick B; Pantel K; Stosiek P; Hosch S; Thetter O; Izbicki JR
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():810-3. PubMed ID: 9101995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global levels of histone modifications predict prostate cancer recurrence.
    Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
    Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.
    Pirinen R; Leinonen T; Böhm J; Johansson R; Ropponen K; Kumpulainen E; Kosma VM
    Hum Pathol; 2005 Jan; 36(1):44-50. PubMed ID: 15712181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
    I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
    Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
    J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
    Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
    Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
    Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
    Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
    Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.